Ascentage Pharma Group International (AAPG) News Today $18.70 +1.00 (+5.65%) As of 04/11/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Ascentage Pharma Group International (NASDAQ:AAPG) Shares Down 4% - Time to Sell?Ascentage Pharma Group International (NASDAQ:AAPG) Shares Down 4% - Here's What HappenedApril 10 at 1:22 PM | marketbeat.comAscentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - Should You Sell?Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - Time to Sell?April 9 at 7:42 PM | marketbeat.comAscentage Pharma Group International (NASDAQ:AAPG) Sets New 12-Month High - What's Next?Ascentage Pharma Group International (NASDAQ:AAPG) Hits New 12-Month High - Should You Buy?April 4, 2025 | marketbeat.comAscentage Pharma Group International (NASDAQ:AAPG) Stock Price Up 5.1% - What's Next?Ascentage Pharma Group International (NASDAQ:AAPG) Shares Up 5.1% - Here's What HappenedApril 3, 2025 | marketbeat.comAscentage Pharma Group International (NASDAQ:AAPG) Sets New 52-Week High - Here's What HappenedAscentage Pharma Group International (NASDAQ:AAPG) Hits New 1-Year High - Time to Buy?March 29, 2025 | marketbeat.comAscentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - What's Next?Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Still a Buy?March 28, 2025 | marketbeat.comAscentage Pharma Group International (NASDAQ:AAPG) Earns Overweight Rating from Analysts at JPMorgan Chase & Co.JPMorgan Chase & Co. initiated coverage on Ascentage Pharma Group International in a research report on Thursday. They issued an "overweight" rating on the stock.March 28, 2025 | marketbeat.comChinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorganMarch 27, 2025 | benzinga.comAscentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2025March 25, 2025 | globenewswire.comAscentage Pharma Group Int Ltd (AAPG)March 18, 2025 | investing.comAAPG Ascentage Pharma Group InternationalMarch 18, 2025 | seekingalpha.comAscentage Pharma to Report Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025March 12, 2025 | globenewswire.comOlverembatinib Granted Breakthrough Therapy Designation for the Treatment of Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)March 5, 2025 | globenewswire.comAscentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - Time to Sell?Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - What's Next?March 1, 2025 | marketbeat.comAscentage Pharma Group International's Quiet Period Set To End on March 5th (NASDAQ:AAPG)Ascentage Pharma Group International's (NASDAQ:AAPG - Get Free Report) quiet period will end on Wednesday, March 5th. Ascentage Pharma Group International had issued 7,325,000 shares in its initial public offering on January 24th. The total size of the offering was $126,356,250 based on an initial share price of $17.25. During Ascentage Pharma Group International's quiet period, underwriters and any insiders involved in the IPO are prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.February 26, 2025 | marketbeat.comAscentage Pharma Group International (NASDAQ:AAPG) Trading Down 7.2% - What's Next?Ascentage Pharma Group International (NASDAQ:AAPG) Shares Down 7.2% - Here's What HappenedFebruary 24, 2025 | marketbeat.comAscentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Time to Buy?Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Still a Buy?February 22, 2025 | marketbeat.comAscentage Pharma Group International (NASDAQ:AAPG) Hits New 52-Week High - Here's What HappenedAscentage Pharma Group International (NASDAQ:AAPG) Hits New 52-Week High - Here's WhyFebruary 20, 2025 | marketbeat.comAscentage Pharma Group International (NASDAQ:AAPG) Shares Down 2.1% - Here's WhyAscentage Pharma Group International (NASDAQ:AAPG) Trading Down 2.1% - Here's WhyFebruary 13, 2025 | marketbeat.comAscentage Pharma Announces Partial Exercise of Underwriters' Option to Purchase Additional American Depositary SharesFebruary 7, 2025 | globenewswire.com Remove Ads Get Ascentage Pharma Group International News Delivered to You Automatically Sign up to receive the latest news and ratings for AAPG and its competitors with MarketBeat's FREE daily newsletter. Email Address AAPG Media Mentions By Week AAPG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AAPG News Sentiment▼1.040.95▲Average Medical News Sentiment AAPG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AAPG Articles This Week▼32▲AAPG Articles Average Week Remove Ads Get Ascentage Pharma Group International News Delivered to You Automatically Sign up to receive the latest news and ratings for AAPG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ROIV News LNTH News LEGN News BBIO News TGTX News RVMD News SRPT News BPMC News KRYS News AXSM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AAPG) was last updated on 4/12/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredWARNING to All American InvestorsForget the headlines about the "trade war." This is where a real military showdown between China and the U....Behind the Markets | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredPlease — Don’t PanicMarkets are in turmoil — but TradeSmith CEO Keith Kaplan says panic isn’t the answer. Instead, he believes thi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ascentage Pharma Group International Please log in to your account or sign up in order to add this asset to your watchlist. Share Ascentage Pharma Group International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.